Thirteen emerging startup life science companies will share the spotlight at the annual Life Science Conference put on by the Council for Entrepreneurial Development, NCBIO and the North Carolina Biotechnology Center in Raleigh.
Titled “#TheNext10,” the conference is set for March 3-4.
Four “company showcase” presentations over the two days will include presentations by the companies with entrepreneurs that have earned their spurs through their own startups serving as moderators.
Showcase #1 – BioPharma Track
Led by: Bob Schotzinger, President, CEO and Director, Viamet Pharmaceuticals
- Spyryx
- Symberix
- T3D Therapeutics
Showcase #2 – Diagnostic Track
Led by: John Ryals, President, CEO, Chairman, Metabolon
- Baebies
- GeneCentric Diagnostics, Inc.
- TouchCare Health
Showcase #3 – Device Track
Led by: Tim Willis, President, CEO, and Co-Founder, TearScience
- NeuroTronik
- Novocor Medical Systems
- Physcient
Showcase #4 – BioPharma Track
Led by: Neal Fowler, Chief Executive Officer, Liquidia Technologies
- BioResource International
- G1 Therapeutics
- Novan Therapeutics
- Vascular Pharmaceuticals
For more information about the conference, visit: http://www.cednc.org/lifescience/registration/
